{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:02:56Z","timestamp":1778662976814,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["420501\/2018-5"],"award-info":[{"award-number":["420501\/2018-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["424542\/2016-1"],"award-info":[{"award-number":["424542\/2016-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.htct.2020.05.006","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T23:05:28Z","timestamp":1593212728000},"page":"377-381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["c.9253-6T > c REV3L: A novel marker of poor prognosis in Myelodysplastic syndrome"],"prefix":"10.1016","volume":"43","author":[{"given":"Roberta Taiane G. de","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo Gabriel. F.","family":"Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2431-4779","authenticated-orcid":false,"given":"Howard L.R.","family":"Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna B.C.","family":"Riello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela de Paula","family":"Borges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle Melo","family":"Cavalcante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia M.M.","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3546-0974","authenticated-orcid":false,"given":"Ronald F.","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"364","key":"10.1016\/j.htct.2020.05.006_bib0005","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","article-title":"Clinical effect of point mutations in myelodysplastic syndromes","volume":"30","author":"Bejar","year":"2011","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.htct.2020.05.006_bib0010","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood."},{"key":"10.1016\/j.htct.2020.05.006_bib0015","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMra0804615","article-title":"DNA damage, aging, and cancer","volume":"361","author":"Hoeijmakers","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.htct.2020.05.006_bib0020","first-page":"107","article-title":"DNA damage tolerance: a double-edged sword guarding the genome","volume":"2","author":"Ghosal","year":"2013","journal-title":"Transl Cancer Res."},{"issue":"August","key":"10.1016\/j.htct.2020.05.006_bib0025","article-title":"Eukaryotic translesion synthesis: Choosing the right tool for the job","author":"Powers","year":"2018","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.htct.2020.05.006_bib0030","first-page":"88","volume":"Vol. 2","year":"2008"},{"issue":"1","key":"10.1016\/j.htct.2020.05.006_bib0035","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/MMBR.00034-08","article-title":"Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance","volume":"73","author":"Waters","year":"2009","journal-title":"Microbiol Mol Biol Rev"},{"issue":"1","key":"10.1016\/j.htct.2020.05.006_bib0040","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/cr.2007.117","article-title":"DNA polymerase zeta (pol zeta) in higher eukaryotes","volume":"18","author":"Gan","year":"2008","journal-title":"Cell Res"},{"issue":"2","key":"10.1016\/j.htct.2020.05.006_bib0045","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrc2998","article-title":"DNA polymerases and cancer","volume":"11","author":"Lange","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.htct.2020.05.006_bib0050","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.1038\/ncomms8199","article-title":"De novo mutations in PLXND1 and REV3L cause M\u00f6bius syndrome","volume":"6","author":"Tomas-Roca","year":"2015","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.htct.2020.05.006_bib0055","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1038\/bcj.2013.46","article-title":"Acute promyelocytic leukemias share cooperative mutations with other myeloid-leukemia subgroups","volume":"3","author":"Riva","year":"2013","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.htct.2020.05.006_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005759","article-title":"The Polymerase Activity of Mammalian DNA Pol \u03b6 Is Specifically Required for Cell and Embryonic Viability","volume":"12","author":"Lange","year":"2016","journal-title":"PLoS Genet"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S253113792030078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S253113792030078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:33:26Z","timestamp":1762868006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S253113792030078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S253113792030078X"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2020.05.006","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"c.9253-6T>c REV3L: A novel marker of poor prognosis in Myelodysplastic syndrome","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2020.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Editora Ltda. on behalf of Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular.","name":"copyright","label":"Copyright"}]}}